Publicaciones en las que colabora con MARÍA ESTEFANÍA MORENO GORDALIZA (23)

2024

  1. Human intake assessment of triclosan associated with the daily use of polypropylene-made antimicrobial food packaging

    Food Chemistry, Vol. 451

  2. Untargeted metabolomics analysis of serum and urine unveils the protective effect of cilastatin on altered metabolic pathways during cisplatin-induced acute kidney injury

    Biochemical Pharmacology, Vol. 227

2023

  1. Risk assessment of silver and microplastics release from antibacterial food containers under conventional use and microwave heating

    Food Chemistry, Vol. 420

2022

  1. Safety assessment of commercial antimicrobial food packaging: Triclosan and microplastics, a closer look

    Food Packaging and Shelf Life, Vol. 31

2021

  1. Lipidomics reveals cisplatin-induced renal lipid alterations during acute kidney injury and their attenuation by cilastatin

    International Journal of Molecular Sciences, Vol. 22, Núm. 22

2019

  1. Differences in binding kinetics, bond strength and adduct formation between Pt-based drugs and S- or N-donor groups: A comparative study using mass spectrometry techniques

    European Journal of Pharmaceutical Sciences, Vol. 132, pp. 96-105

2018

  1. Lipid imaging for visualizing cilastatin amelioration of cisplatin-induced nephrotoxicity

    Journal of Lipid Research, Vol. 59, Núm. 9, pp. 1561-1574

2017

  1. Dual Internal Standards with Metals and Molecules for MALDI Imaging of Kidney Lipids

    Analytical Chemistry, Vol. 89, Núm. 23, pp. 12727-12734

  2. MALDI-LTQ-Orbitrap mass spectrometry imaging for lipidomic analysis in kidney under cisplatin chemotherapy

    Talanta, Vol. 164, pp. 16-26

2015

  1. A shotgun approach for the identification of platinum-protein complexes

    Analytical and Bioanalytical Chemistry, Vol. 407, Núm. 9, pp. 2393-2403

2014

  1. Combining TBP-based rOFFGEL-IEF with FASP and nLC-ESI-LTQ-MS/MS for the analysis of cisplatin-binding proteins in rat kidney

    Talanta, Vol. 120, pp. 433-442

  2. Thiol-free reducing agents in electrophoretic separations and FASP proteolytic digestions for the analysis of metal-binding proteins

    MethodsX, Vol. 1, pp. e175-e180

2013

  1. TCEP-based rSDS-PAGE and nLC-ESI-LTQ-MS/MS for oxaliplatin metalloproteomic analysis

    Talanta, Vol. 116, pp. 581-592

2012

  1. Characterization of Pt-protein complexes by nHPLC-ESI-LTQ MS/MS using a gel-based bottom-up approach

    Talanta, Vol. 88, pp. 599-608

  2. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats

    Kidney International, Vol. 82, Núm. 6, pp. 652-663

  3. Estrategias bioanalíticas en estudios metalómicos de fármacos de platino

    Anales de Química de la RSEQ, Núm. 1, pp. 21-28

  4. LA-ICP-MS and nHPLC-ESI-LTQ-FT-MS/MS for the analysis of cisplatin-protein complexes separated by two dimensional gel electrophoresis in biological samples

    Journal of Analytical Atomic Spectrometry, Vol. 27, Núm. 9, pp. 1474-1483

2011

  1. Elemental bioimaging in kidney by LA-ICP-MS as a tool to study nephrotoxicity and renal protective strategies in cisplatin therapies

    Analytical Chemistry, Vol. 83, Núm. 20, pp. 7933-7940

  2. OFFGEL isoelectric focusing and polyacrylamide gel electrophoresis separation of platinum-binding proteins

    Journal of Chromatography A, Vol. 1218, Núm. 9, pp. 1281-1290

2010

  1. Analytical methodologies for metallomics studies of antitumor Pt-containing drugs

    Metallomics, Vol. 2, Núm. 1, pp. 19-38